The purpose of the present study was to evaluate the expression of KPNA2 in osteosarcoma, chondrosarcoma and ES samples using immunohistochemistry to confirm its potential diagnostic utility as a novel molecular marker for discriminating osteosarcoma from other primary bone sarcomas. Here, KPNA2 is linked to chondrosarcoma.